These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28551428)

  • 1. Delivery of Riboflavin-5'-Monophosphate Into the Cornea: Can Liposomes Provide Any Enhancement Effects?
    Kandzija N; Khutoryanskiy VV
    J Pharm Sci; 2017 Oct; 106(10):3041-3049. PubMed ID: 28551428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of corneal permeation of riboflavin-5'-phosphate through vitamin E TPGS: a promising approach in corneal trans-epithelial cross linking treatment.
    Ostacolo C; Caruso C; Tronino D; Troisi S; Laneri S; Pacente L; Del Prete A; Sacchi A
    Int J Pharm; 2013 Jan; 440(2):148-53. PubMed ID: 23046664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiality of microemulsion systems in treatment of ophthalmic disorders: Keratoconus and dry eye syndrome - In vivo study.
    Lidich N; Garti-Levy S; Aserin A; Garti N
    Colloids Surf B Biointerfaces; 2019 Jan; 173():226-232. PubMed ID: 30300828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating in vivo delivery of riboflavin with coulomb-controlled iontophoresis for corneal collagen cross-linking: a pilot study.
    Arboleda A; Kowalczuk L; Savoldelli M; Klein C; Ladraa S; Naud MC; Aguilar MC; Parel JM; Behar-Cohen F
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2731-8. PubMed ID: 24667860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological and functional correlations in riboflavin UV A corneal collagen cross-linking for keratoconus.
    Mazzotta C; Caporossi T; Denaro R; Bovone C; Sparano C; Paradiso A; Baiocchi S; Caporossi A
    Acta Ophthalmol; 2012 May; 90(3):259-65. PubMed ID: 20456255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking.
    Conde Penedo A; Díaz Tomé V; Fernández Ferreiro A; González Barcia M; Otero Espinar FJ
    Eur J Pharm Biopharm; 2021 May; 162():12-22. PubMed ID: 33667681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal absorption of a new riboflavin-nanostructured system for transepithelial collagen cross-linking.
    Bottos KM; Oliveira AG; Bersanetti PA; Nogueira RF; Lima-Filho AA; Cardillo JA; Schor P; Chamon W
    PLoS One; 2013; 8(6):e66408. PubMed ID: 23785497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of in vivo iontophoresis-assisted corneal collagen cross-linking for keratoconus: An immunohistochemical study.
    Manetti M; Favuzza E; Sgambati E; Mencucci R; Marini M
    Acta Histochem; 2017 Apr; 119(3):343-347. PubMed ID: 28215504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riboflavin/Ultraviolet A corneal collagen cross-linking for the treatment of keratoconus: visual outcomes and Scheimpflug analysis.
    Henriquez MA; Izquierdo L; Bernilla C; Zakrzewski PA; Mannis M
    Cornea; 2011 Mar; 30(3):281-6. PubMed ID: 21045662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study.
    Caporossi A; Baiocchi S; Mazzotta C; Traversi C; Caporossi T
    J Cataract Refract Surg; 2006 May; 32(5):837-45. PubMed ID: 16765803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment.
    Aytekin E; Öztürk N; Vural İ; Polat HK; Çakmak HB; Çalış S; Pehlivan SB
    J Control Release; 2020 Aug; 324():238-249. PubMed ID: 32413453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linking to halt the progression of keratoconus.
    O'Brart DP; Kwong TQ; Patel P; McDonald RJ; O'Brart NA
    Br J Ophthalmol; 2013 Apr; 97(4):433-7. PubMed ID: 23385632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal Cross-Linking: An Example of Photoinduced Polymerization as a Treatment Modality in Keratoconus.
    Kubrak-Kisza M; Kisza KJ; Misiuk-Hojło M
    Polim Med; 2016; 46(1):89-94. PubMed ID: 28397423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomechanical Strengthening of the Human Cornea Induced by Nanoplatform-Based Transepithelial Riboflavin/UV-A Corneal Cross-Linking.
    Labate C; Lombardo M; Lombardo G; De Santo MP
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):179-184. PubMed ID: 28114577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of keratoconus by collagen cross linking].
    Wollensak G; Spörl E; Seiler T
    Ophthalmologe; 2003 Jan; 100(1):44-9. PubMed ID: 12557025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pressure measurements after corneal collagen crosslinking with riboflavin and ultraviolet A in eyes with keratoconus.
    Kymionis GD; Grentzelos MA; Kounis GA; Portaliou DM; Detorakis ET; Magarakis M; Karampatakis VE; Pallikaris IG
    J Cataract Refract Surg; 2010 Oct; 36(10):1724-7. PubMed ID: 20870119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative corneal thickness measurements during corneal collagen cross-linking with isotonic riboflavin solution without dextran in corneal ectasia.
    Cınar Y; Cingü AK; Sahin A; Türkcü FM; Yüksel H; Caca I
    Cutan Ocul Toxicol; 2014 Mar; 33(1):28-31. PubMed ID: 23692299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative corneal thickness measurement by optical coherence tomography in keratoconic patients undergoing corneal collagen cross-linking.
    Mazzotta C; Caragiuli S
    Am J Ophthalmol; 2014 Jun; 157(6):1156-62. PubMed ID: 24582997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and corneal biomechanical changes after collagen cross-linking with riboflavin and UV irradiation in patients with progressive keratoconus: results after 2 years of follow-up.
    Goldich Y; Marcovich AL; Barkana Y; Mandel Y; Hirsh A; Morad Y; Avni I; Zadok D
    Cornea; 2012 Jun; 31(6):609-14. PubMed ID: 22378112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crown Ethers: Novel Permeability Enhancers for Ocular Drug Delivery?
    Morrison PWJ; Porfiryeva NN; Chahal S; Salakhov IA; Lacourt C; Semina II; Moustafine RI; Khutoryanskiy VV
    Mol Pharm; 2017 Oct; 14(10):3528-3538. PubMed ID: 28825493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.